Literature DB >> 18772143

Disease-causing mutation in GPR54 reveals the importance of the second intracellular loop for class A G-protein-coupled receptor function.

Jennifer L Wacker1, David B Feller, Xiao-Bo Tang, Mia C Defino, Yuree Namkung, John S Lyssand, Andrew J Mhyre, Xu Tan, Jill B Jensen, Chris Hague.   

Abstract

The G-protein-coupled receptor (GPCR) GPR54 is essential for the development and maintenance of reproductive function in mammals. A point mutation (L148S) in the second intracellular loop (IL2) of GPR54 causes idiopathic hypogonadotropic hypogonadism, a disorder characterized by delayed puberty and infertility. Here, we characterize the molecular mechanism by which the L148S mutation causes disease and address the role of IL2 in Class A GPCR function. Biochemical, immunocytochemical, and pharmacological analysis demonstrates that the mutation does not affect the expression, ligand binding properties, or protein interaction network of GPR54. In contrast, diverse GPR54 functional responses are markedly inhibited by the L148S mutation. Importantly, the leucine residue at this position is highly conserved among class A GPCRs. Indeed, mutating the corresponding leucine of the alpha(1A)-AR recapitulates the effects observed with L148S GPR54, suggesting the critical importance of this hydrophobic IL2 residue for Class A GPCR functional coupling. Interestingly, co-immunoprecipitation studies indicate that L148S does not hinder the association of Galpha subunits with GPR54. However, fluorescence resonance energy transfer analysis strongly suggests that L148S impairs the ligand-induced catalytic activation of Galpha. Combining our data with a predictive Class A GPCR/Galpha model suggests that IL2 domains contain a conserved hydrophobic motif that, upon agonist stimulation, might stabilize the switch II region of Galpha. Such an interaction could promote opening of switch II of Galpha to facilitate GDP-GTP exchange and coupling to downstream signaling responses. Importantly, mutations that disrupt this key hydrophobic interface can manifest as human disease.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18772143      PMCID: PMC2576551          DOI: 10.1074/jbc.M805251200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  44 in total

1.  Mapping of contact sites in complex formation between transducin and light-activated rhodopsin by covalent crosslinking: use of a photoactivatable reagent.

Authors:  K Cai; Y Itoh; H G Khorana
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-24       Impact factor: 11.205

Review 2.  Regulation of G protein-coupled receptor signaling by scaffold proteins.

Authors:  Randy A Hall; Robert J Lefkowitz
Journal:  Circ Res       Date:  2002-10-18       Impact factor: 17.367

3.  A cell-based immunocytochemical assay for monitoring kinase signaling pathways and drug efficacy.

Authors:  Huaxian Chen; Joy Kovar; Sean Sissons; Karen Cox; William Matter; Fred Chadwell; Peng Luan; Chris J Vlahos; Amy Schutz-Geschwender; D Michael Olive
Journal:  Anal Biochem       Date:  2005-03-01       Impact factor: 3.365

4.  'Effective inefficiency': cellular control of protein trafficking as a mechanism of post-translational regulation.

Authors:  P Michael Conn; Jo Ann Janovick; Shaun P Brothers; Paul E Knollman
Journal:  J Endocrinol       Date:  2006-07       Impact factor: 4.286

Review 5.  The highly conserved DRY motif of class A G protein-coupled receptors: beyond the ground state.

Authors:  G Enrico Rovati; Valérie Capra; Richard R Neubig
Journal:  Mol Pharmacol       Date:  2006-12-27       Impact factor: 4.436

6.  Structural basis for nucleotide exchange on G alpha i subunits and receptor coupling specificity.

Authors:  Christopher A Johnston; David P Siderovski
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-30       Impact factor: 11.205

Review 7.  Structural basis of function in heterotrimeric G proteins.

Authors:  William M Oldham; Heidi E Hamm
Journal:  Q Rev Biophys       Date:  2006-08-21       Impact factor: 5.318

8.  Purification and identification of G protein-coupled receptor protein complexes under native conditions.

Authors:  Avais M Daulat; Pascal Maurice; Carine Froment; Jean-Luc Guillaume; Cédric Broussard; Bernard Monsarrat; Philippe Delagrange; Ralf Jockers
Journal:  Mol Cell Proteomics       Date:  2007-01-09       Impact factor: 5.911

Review 9.  Mechanisms of Disease: the first kiss-a crucial role for kisspeptin-1 and its receptor, G-protein-coupled receptor 54, in puberty and reproduction.

Authors:  Stephanie B Seminara
Journal:  Nat Clin Pract Endocrinol Metab       Date:  2006-06

10.  Two novel mutations in the gonadotropin-releasing hormone receptor gene in Brazilian patients with hypogonadotropic hypogonadism and normal olfaction.

Authors:  E M Costa; G Y Bedecarrats; B B Mendonca; I J Arnhold; U B Kaiser; A C Latronico
Journal:  J Clin Endocrinol Metab       Date:  2001-06       Impact factor: 5.958

View more
  28 in total

1.  Structural determinants in the second intracellular loop of the human cannabinoid CB1 receptor mediate selective coupling to G(s) and G(i).

Authors:  X P Chen; W Yang; Y Fan; J S Luo; K Hong; Z Wang; J F Yan; X Chen; J X Lu; J L Benovic; N M Zhou
Journal:  Br J Pharmacol       Date:  2010-12       Impact factor: 8.739

2.  Alpha-dystrobrevin-1 recruits alpha-catulin to the alpha1D-adrenergic receptor/dystrophin-associated protein complex signalosome.

Authors:  John S Lyssand; Jennifer L Whiting; Kyung-Soon Lee; Ryan Kastl; Jennifer L Wacker; Michael R Bruchas; Mayumi Miyatake; Lorene K Langeberg; Charles Chavkin; John D Scott; Richard G Gardner; Marvin E Adams; Chris Hague
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-29       Impact factor: 11.205

Review 3.  International Union of Basic and Clinical Pharmacology. LXXVII. Kisspeptin receptor nomenclature, distribution, and function.

Authors:  Helen R Kirby; Janet J Maguire; William H Colledge; Anthony P Davenport
Journal:  Pharmacol Rev       Date:  2010-12       Impact factor: 25.468

Review 4.  The genetic and molecular basis of idiopathic hypogonadotropic hypogonadism.

Authors:  Suzy D C Bianco; Ursula B Kaiser
Journal:  Nat Rev Endocrinol       Date:  2009-08-25       Impact factor: 43.330

Review 5.  G protein-coupled receptors involved in GnRH regulation: molecular insights from human disease.

Authors:  Sekoni D Noel; Ursula B Kaiser
Journal:  Mol Cell Endocrinol       Date:  2011-06-29       Impact factor: 4.102

6.  KISS1R signals independently of Gαq/11 and triggers LH secretion via the β-arrestin pathway in the male mouse.

Authors:  Maryse Ahow; Le Min; Macarena Pampillo; Connor Nash; Junping Wen; Kathleen Soltis; Rona S Carroll; Christine A Glidewell-Kenney; Pamela L Mellon; Moshmi Bhattacharya; Stuart A Tobet; Ursula B Kaiser; Andy V Babwah
Journal:  Endocrinology       Date:  2014-08-22       Impact factor: 4.736

Review 7.  Kisspeptin signaling in the brain.

Authors:  Amy E Oakley; Donald K Clifton; Robert A Steiner
Journal:  Endocr Rev       Date:  2009-09-21       Impact factor: 19.871

8.  Phosphorylation of the mu-opioid receptor at tyrosine 166 (Tyr3.51) in the DRY motif reduces agonist efficacy.

Authors:  Cecilea C Clayton; Michael R Bruchas; Michael L Lee; Charles Chavkin
Journal:  Mol Pharmacol       Date:  2009-12-03       Impact factor: 4.436

9.  GPR54 regulates ERK1/2 activity and hypothalamic gene expression in a Gα(q/11) and β-arrestin-dependent manner.

Authors:  Jacob M Szereszewski; Macarena Pampillo; Maryse R Ahow; Stefan Offermanns; Moshmi Bhattacharya; Andy V Babwah
Journal:  PLoS One       Date:  2010-09-23       Impact factor: 3.240

10.  Dynamic kisspeptin receptor trafficking modulates kisspeptin-mediated calcium signaling.

Authors:  Le Min; Kathleen Soltis; Ana Claudia S Reis; Shuyun Xu; Wendy Kuohung; Manisha Jain; Rona S Carroll; Ursula B Kaiser
Journal:  Mol Endocrinol       Date:  2013-12-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.